Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solriamfetol Driving Performance in Narcolepsy
NCT02806908Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jun 2016
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of solriamfetol in narcolepsy, sponsored by Jazz Pharmaceuticals plc. Started Jun 2016; status: completed.
02
Drugs
solriamfetol
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT02806908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806908.